Asia-Pacific animal vaccine market is estimated to grow at a CAGR of around 7.6% during the forecast period. Asia-Pacific has a potential market owing to the increasing animal husbandry practices with an improvement in the management of farms. Moreover, the advancement in biotechnological research is supporting to drive the market in the region. The large breeding companies in the region are increasingly inclining towards the adoption of high-quality vaccines, which are nearly 5-15 times costly than vaccines purchased under the policy. Significant prevalence of livestock diseases is expected to offer bright prospects in the growth of the animal vaccine market in the region. Further, the rapid industrialization of the entire livestock, increasing state government initiatives with the introduction of several mass vaccination programs are some other factors augmenting the market growth in the region.
(Get 15% Discount on Buying this Report)
Get Report Sample Copy @ https://www.omrglobal.com/request-sample/asia-pacific-animal-vaccine-market
Some crucial players in the market include Zoetis, Inc., Bayer AG, Boehringer Ingelheim International GmbH, Hester Biosciences Ltd., Merck & Co., Inc., and Novartis International AG. In order to survive in the market, these players are adopting crucial strategies, such as mergers and acquisitions, product launches, R&D, and partnerships and collaborations.
A Full Report of Asia-Pacific Animal Vaccine Market is Available at: https://www.omrglobal.com/industry-reports/asia-pacific-animal-vaccine-market
Asia-Pacific Animal Vaccine Market Segmentation
By Type
- Porcine Vaccines
- Poultry Vaccines
- Livestock Vaccines
- Aquaculture Vaccines
- Companion Animal Vaccines
- Other Animal Vaccines
By Technology
- Live Attenuated Vaccine
- Killed/Inactive Vaccine
- Recombinant Vaccine
- Vectored Vaccine
- Subunit Vaccine
- DNA Vaccine
- Chimeric Vaccine
- Others
Regional Analysis
- China
- India
- Japan
- Rest of Asia-Pacific
Company Profiles
- Bayer AG
- Bio-Med (P) Ltd.
- Biovet Pvt. Ltd.
- Boehringer Ingelheim International GmbH
- Brilliant Bio Pharma Private Limited (BBPL)
- Hester Biosciences Ltd.
- Indovax Pvt. Ltd.
- Merck & Co., Inc.
- Nisseiken Co. Ltd.
- Novartis International AG
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
